Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 21 | 2021 | 301 | 2.850 |
Why?
|
Hydroxyprostaglandin Dehydrogenases | 12 | 2013 | 16 | 2.520 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 12 | 2013 | 17 | 2.480 |
Why?
|
Biomarkers, Tumor | 16 | 2020 | 404 | 2.010 |
Why?
|
Glioma | 13 | 2021 | 117 | 1.960 |
Why?
|
Adenocarcinoma | 7 | 2019 | 297 | 1.490 |
Why?
|
Immunohistochemistry | 25 | 2021 | 461 | 1.410 |
Why?
|
Pancreatic Neoplasms | 8 | 2022 | 540 | 1.020 |
Why?
|
Humans | 96 | 2022 | 27968 | 0.970 |
Why?
|
Urinary Bladder | 10 | 2018 | 119 | 0.920 |
Why?
|
Prostatic Neoplasms | 9 | 2019 | 277 | 0.860 |
Why?
|
Neuroectodermal Tumors, Primitive | 4 | 2015 | 10 | 0.860 |
Why?
|
Regeneration | 12 | 2020 | 77 | 0.770 |
Why?
|
Lung Neoplasms | 4 | 2016 | 353 | 0.770 |
Why?
|
Aldo-Keto Reductase Family 1 Member C3 | 12 | 2017 | 21 | 0.760 |
Why?
|
Glioblastoma | 5 | 2021 | 105 | 0.730 |
Why?
|
Sarcoma, Ewing | 2 | 2015 | 15 | 0.700 |
Why?
|
Stomach Neoplasms | 3 | 2019 | 23 | 0.680 |
Why?
|
Cerebellar Neoplasms | 4 | 2019 | 28 | 0.680 |
Why?
|
Medulloblastoma | 3 | 2015 | 18 | 0.660 |
Why?
|
Male | 42 | 2021 | 13424 | 0.620 |
Why?
|
Cerebral Ventricle Neoplasms | 3 | 2019 | 7 | 0.610 |
Why?
|
Carcinoma | 2 | 2021 | 74 | 0.610 |
Why?
|
Melanoma | 3 | 2014 | 140 | 0.580 |
Why?
|
Animals | 45 | 2022 | 10370 | 0.580 |
Why?
|
Female | 44 | 2021 | 15074 | 0.580 |
Why?
|
Breast Neoplasms | 4 | 2019 | 458 | 0.560 |
Why?
|
Third Ventricle | 2 | 2014 | 9 | 0.550 |
Why?
|
Intestine, Small | 7 | 2018 | 66 | 0.540 |
Why?
|
Cell Line, Tumor | 21 | 2022 | 1314 | 0.540 |
Why?
|
Neuroendocrine Tumors | 2 | 2015 | 29 | 0.540 |
Why?
|
Neoplasms, Neuroepithelial | 2 | 2018 | 9 | 0.540 |
Why?
|
Mutation | 9 | 2021 | 843 | 0.500 |
Why?
|
Ependymoma | 2 | 2014 | 11 | 0.500 |
Why?
|
Intestinal Mucosa | 6 | 2018 | 197 | 0.500 |
Why?
|
Biocompatible Materials | 5 | 2020 | 95 | 0.490 |
Why?
|
Brain | 2 | 2021 | 739 | 0.490 |
Why?
|
Zinc Finger E-box-Binding Homeobox 1 | 3 | 2021 | 26 | 0.480 |
Why?
|
Urothelium | 5 | 2018 | 35 | 0.480 |
Why?
|
Tissue Scaffolds | 5 | 2021 | 88 | 0.470 |
Why?
|
Carcinoma, Renal Cell | 2 | 2020 | 77 | 0.470 |
Why?
|
Palatal Neoplasms | 1 | 2014 | 2 | 0.470 |
Why?
|
Palate, Hard | 1 | 2014 | 2 | 0.470 |
Why?
|
Meningioma | 2 | 2020 | 79 | 0.470 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2012 | 28 | 0.470 |
Why?
|
Skin Neoplasms | 2 | 2013 | 143 | 0.470 |
Why?
|
Prostate | 6 | 2019 | 52 | 0.470 |
Why?
|
Oncogene Proteins, Fusion | 5 | 2017 | 22 | 0.470 |
Why?
|
Cell Proliferation | 16 | 2022 | 802 | 0.460 |
Why?
|
Rhabdoid Tumor | 2 | 2004 | 9 | 0.460 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 101 | 0.460 |
Why?
|
Salivary Gland Neoplasms | 1 | 2014 | 22 | 0.460 |
Why?
|
Computer-Assisted Instruction | 2 | 2012 | 30 | 0.450 |
Why?
|
Apoptosis | 8 | 2017 | 772 | 0.440 |
Why?
|
Middle Aged | 20 | 2021 | 7111 | 0.440 |
Why?
|
Aged | 17 | 2021 | 5383 | 0.440 |
Why?
|
Prognosis | 12 | 2021 | 802 | 0.430 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2013 | 7 | 0.420 |
Why?
|
Antibodies, Monoclonal | 6 | 2021 | 329 | 0.420 |
Why?
|
Boswellia | 4 | 2016 | 4 | 0.410 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2013 | 39 | 0.410 |
Why?
|
Signal Transduction | 13 | 2021 | 1433 | 0.400 |
Why?
|
Magnetic Resonance Imaging | 8 | 2019 | 817 | 0.400 |
Why?
|
Adult | 20 | 2021 | 7703 | 0.400 |
Why?
|
Mice | 21 | 2022 | 4621 | 0.390 |
Why?
|
Esophagogastric Junction | 1 | 2012 | 6 | 0.390 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2012 | 9 | 0.390 |
Why?
|
Pinealoma | 1 | 2012 | 4 | 0.390 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2012 | 14 | 0.390 |
Why?
|
Swine | 13 | 2022 | 236 | 0.380 |
Why?
|
Hyaluronic Acid | 4 | 2021 | 95 | 0.380 |
Why?
|
Pathology, Clinical | 1 | 2012 | 11 | 0.380 |
Why?
|
Esophageal Neoplasms | 1 | 2012 | 32 | 0.380 |
Why?
|
Internet | 2 | 2012 | 124 | 0.380 |
Why?
|
Stress, Mechanical | 3 | 2021 | 115 | 0.370 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2021 | 77 | 0.370 |
Why?
|
Cachexia | 2 | 2022 | 53 | 0.360 |
Why?
|
Aged, 80 and over | 10 | 2021 | 2015 | 0.360 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2017 | 20 | 0.360 |
Why?
|
Education, Medical | 1 | 2012 | 66 | 0.360 |
Why?
|
Endometrial Hyperplasia | 1 | 2010 | 6 | 0.350 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 163 | 0.340 |
Why?
|
Cation Transport Proteins | 3 | 2021 | 60 | 0.340 |
Why?
|
Neurilemmoma | 1 | 2010 | 13 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2021 | 461 | 0.340 |
Why?
|
Neovascularization, Pathologic | 3 | 2017 | 149 | 0.330 |
Why?
|
Aortic Valve | 2 | 2021 | 92 | 0.330 |
Why?
|
Wilms Tumor | 1 | 2009 | 8 | 0.330 |
Why?
|
Neurocytoma | 2 | 2015 | 2 | 0.330 |
Why?
|
Hemangioblastoma | 2 | 2020 | 13 | 0.330 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2009 | 55 | 0.320 |
Why?
|
Pathology | 1 | 2009 | 8 | 0.320 |
Why?
|
Tracheal Stenosis | 2 | 2020 | 7 | 0.320 |
Why?
|
Neurology | 1 | 2009 | 10 | 0.310 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 123 | 0.310 |
Why?
|
Telomerase | 2 | 2020 | 37 | 0.310 |
Why?
|
Trachea | 2 | 2020 | 26 | 0.310 |
Why?
|
Biopsy | 6 | 2018 | 206 | 0.310 |
Why?
|
Tomography, Optical Coherence | 3 | 2022 | 91 | 0.310 |
Why?
|
MicroRNAs | 3 | 2022 | 294 | 0.300 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 152 | 0.300 |
Why?
|
Endometrial Neoplasms | 1 | 2010 | 189 | 0.300 |
Why?
|
Benzenesulfonates | 3 | 2021 | 18 | 0.290 |
Why?
|
Imines | 3 | 2021 | 21 | 0.290 |
Why?
|
Ovarian Neoplasms | 3 | 2020 | 588 | 0.290 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2019 | 268 | 0.290 |
Why?
|
Rats | 12 | 2021 | 1570 | 0.290 |
Why?
|
Child, Preschool | 7 | 2020 | 1133 | 0.290 |
Why?
|
Oils, Volatile | 3 | 2012 | 4 | 0.280 |
Why?
|
Cell Movement | 5 | 2021 | 365 | 0.270 |
Why?
|
Membrane Proteins | 3 | 2019 | 483 | 0.270 |
Why?
|
Receptors, Androgen | 2 | 2008 | 26 | 0.270 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2016 | 162 | 0.270 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2018 | 26 | 0.260 |
Why?
|
Receptors, GABA-A | 2 | 2017 | 18 | 0.250 |
Why?
|
Astrocytoma | 2 | 2018 | 35 | 0.250 |
Why?
|
Tumor Cells, Cultured | 7 | 2017 | 315 | 0.250 |
Why?
|
Lymphocytes | 2 | 2017 | 90 | 0.250 |
Why?
|
Disease Models, Animal | 12 | 2019 | 1454 | 0.250 |
Why?
|
Tissue Engineering | 6 | 2021 | 152 | 0.240 |
Why?
|
Rats, Sprague-Dawley | 9 | 2020 | 550 | 0.240 |
Why?
|
Spinal Neoplasms | 1 | 2005 | 39 | 0.240 |
Why?
|
Spinal Cord Diseases | 1 | 2005 | 31 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2022 | 155 | 0.230 |
Why?
|
Elastin | 2 | 2021 | 22 | 0.230 |
Why?
|
Printing, Three-Dimensional | 3 | 2021 | 31 | 0.230 |
Why?
|
Adenoma, Pleomorphic | 1 | 2004 | 5 | 0.230 |
Why?
|
Parotid Neoplasms | 1 | 2004 | 4 | 0.230 |
Why?
|
Neoplasms, Second Primary | 1 | 2004 | 21 | 0.220 |
Why?
|
Neoplasm Metastasis | 4 | 2021 | 160 | 0.220 |
Why?
|
Androstane-3,17-diol | 2 | 2017 | 9 | 0.220 |
Why?
|
Tensile Strength | 2 | 2021 | 35 | 0.220 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 473 | 0.210 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 679 | 0.210 |
Why?
|
Integrin alpha3 | 2 | 2021 | 18 | 0.210 |
Why?
|
Nanoparticles | 3 | 2020 | 287 | 0.210 |
Why?
|
Histones | 2 | 2021 | 92 | 0.210 |
Why?
|
Collagen | 2 | 2021 | 156 | 0.210 |
Why?
|
Lipoma | 1 | 2003 | 11 | 0.210 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2021 | 114 | 0.200 |
Why?
|
Hydrogels | 2 | 2021 | 58 | 0.200 |
Why?
|
Frontal Bone | 1 | 2002 | 5 | 0.200 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2002 | 5 | 0.200 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2017 | 31 | 0.200 |
Why?
|
Plant Oils | 2 | 2012 | 10 | 0.200 |
Why?
|
Acetate-CoA Ligase | 1 | 2022 | 9 | 0.200 |
Why?
|
Anesthesia, Epidural | 1 | 2022 | 7 | 0.200 |
Why?
|
Transcription Factors | 3 | 2021 | 520 | 0.200 |
Why?
|
Skull Fractures | 1 | 2002 | 19 | 0.200 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 330 | 0.200 |
Why?
|
Craniocerebral Trauma | 1 | 2002 | 27 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2017 | 119 | 0.190 |
Why?
|
Mice, Nude | 6 | 2019 | 330 | 0.190 |
Why?
|
Lenses | 1 | 2022 | 12 | 0.190 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2022 | 39 | 0.190 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2019 | 31 | 0.190 |
Why?
|
Polyesters | 2 | 2020 | 35 | 0.190 |
Why?
|
Microscopy | 1 | 2022 | 38 | 0.190 |
Why?
|
Nanotubes | 1 | 2021 | 15 | 0.190 |
Why?
|
Bioprinting | 1 | 2021 | 9 | 0.190 |
Why?
|
Oklahoma | 3 | 2020 | 993 | 0.180 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 78 | 0.180 |
Why?
|
Fibrosis | 2 | 2020 | 131 | 0.180 |
Why?
|
Intracellular Membranes | 1 | 2021 | 15 | 0.180 |
Why?
|
Gallbladder Neoplasms | 1 | 2021 | 14 | 0.180 |
Why?
|
Cell Plasticity | 1 | 2021 | 10 | 0.180 |
Why?
|
Adenosine | 1 | 2021 | 33 | 0.180 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 61 | 0.180 |
Why?
|
Brain Stem Neoplasms | 1 | 2020 | 12 | 0.180 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2015 | 75 | 0.180 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2021 | 30 | 0.180 |
Why?
|
DNA Modification Methylases | 1 | 2020 | 13 | 0.180 |
Why?
|
DNA Repair Enzymes | 1 | 2020 | 9 | 0.170 |
Why?
|
rab GTP-Binding Proteins | 1 | 2021 | 33 | 0.170 |
Why?
|
Immunity, Innate | 3 | 2017 | 226 | 0.170 |
Why?
|
Tenofovir | 1 | 2020 | 7 | 0.170 |
Why?
|
Ritonavir | 1 | 2020 | 11 | 0.170 |
Why?
|
Laparoscopy | 1 | 2022 | 146 | 0.170 |
Why?
|
HIV Protease Inhibitors | 1 | 2020 | 14 | 0.170 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 49 | 0.170 |
Why?
|
Zinc | 1 | 2021 | 63 | 0.170 |
Why?
|
Supratentorial Neoplasms | 1 | 2020 | 4 | 0.170 |
Why?
|
Intracranial Aneurysm | 1 | 2021 | 57 | 0.170 |
Why?
|
Child | 7 | 2020 | 2225 | 0.170 |
Why?
|
Zonula Occludens-1 Protein | 2 | 2018 | 17 | 0.170 |
Why?
|
Disease Progression | 6 | 2019 | 472 | 0.170 |
Why?
|
Lateral Ventricles | 1 | 2019 | 8 | 0.170 |
Why?
|
Sulfhydryl Compounds | 1 | 2020 | 29 | 0.170 |
Why?
|
Gene Expression Profiling | 5 | 2019 | 452 | 0.170 |
Why?
|
Kidney Diseases | 1 | 2020 | 60 | 0.160 |
Why?
|
Integrin beta1 | 1 | 2019 | 15 | 0.160 |
Why?
|
Bone Regeneration | 1 | 2020 | 17 | 0.160 |
Why?
|
Skull | 1 | 2020 | 37 | 0.160 |
Why?
|
Corpus Callosum | 1 | 2019 | 19 | 0.160 |
Why?
|
Tendons | 1 | 2020 | 28 | 0.160 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2019 | 48 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 163 | 0.160 |
Why?
|
Survival Rate | 5 | 2021 | 428 | 0.160 |
Why?
|
Diagnosis, Differential | 4 | 2016 | 369 | 0.160 |
Why?
|
Deoxycytidine | 1 | 2019 | 65 | 0.160 |
Why?
|
Cerebral Aqueduct | 1 | 2019 | 4 | 0.160 |
Why?
|
Inferior Colliculi | 1 | 2019 | 4 | 0.160 |
Why?
|
Polyglycolic Acid | 2 | 2010 | 38 | 0.160 |
Why?
|
Bone and Bones | 1 | 2020 | 75 | 0.160 |
Why?
|
Cell Differentiation | 3 | 2017 | 406 | 0.160 |
Why?
|
Receptors, Interleukin-8B | 1 | 2019 | 6 | 0.160 |
Why?
|
Neovascularization, Physiologic | 2 | 2010 | 124 | 0.160 |
Why?
|
Models, Cardiovascular | 1 | 2019 | 47 | 0.160 |
Why?
|
DNA Methylation | 1 | 2020 | 151 | 0.160 |
Why?
|
Neoplasm Staging | 5 | 2021 | 478 | 0.160 |
Why?
|
Patient Positioning | 1 | 2019 | 23 | 0.160 |
Why?
|
Glycosaminoglycans | 1 | 2019 | 54 | 0.150 |
Why?
|
Anti-Infective Agents | 1 | 2020 | 78 | 0.150 |
Why?
|
Immunomodulation | 1 | 2018 | 20 | 0.150 |
Why?
|
Lactic Acid | 2 | 2010 | 92 | 0.150 |
Why?
|
Metal Nanoparticles | 1 | 2020 | 130 | 0.150 |
Why?
|
Lymphangioma | 1 | 2018 | 3 | 0.150 |
Why?
|
Hemangioma | 1 | 2018 | 8 | 0.150 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 15 | 0.150 |
Why?
|
Neoplasm Grading | 2 | 2017 | 104 | 0.150 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2018 | 15 | 0.150 |
Why?
|
DNA Mutational Analysis | 3 | 2013 | 94 | 0.150 |
Why?
|
Cell Communication | 1 | 2019 | 67 | 0.150 |
Why?
|
Arteriovenous Malformations | 1 | 2018 | 16 | 0.150 |
Why?
|
Absorbable Implants | 1 | 2018 | 16 | 0.150 |
Why?
|
Claudin-1 | 1 | 2018 | 7 | 0.150 |
Why?
|
Cysts | 1 | 2018 | 22 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 166 | 0.150 |
Why?
|
Computer Simulation | 1 | 2019 | 230 | 0.150 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2017 | 2 | 0.150 |
Why?
|
HIV Infections | 1 | 2020 | 157 | 0.150 |
Why?
|
Nanofibers | 1 | 2018 | 23 | 0.150 |
Why?
|
Interleukin-18 | 1 | 2017 | 17 | 0.140 |
Why?
|
Anabolic Agents | 1 | 2017 | 12 | 0.140 |
Why?
|
Neuroma, Acoustic | 1 | 2018 | 23 | 0.140 |
Why?
|
Cell Survival | 6 | 2019 | 408 | 0.140 |
Why?
|
Lysophospholipids | 1 | 2018 | 48 | 0.140 |
Why?
|
Transcriptome | 1 | 2019 | 214 | 0.140 |
Why?
|
ErbB Receptors | 2 | 2017 | 100 | 0.140 |
Why?
|
Cell Membrane | 1 | 2019 | 257 | 0.140 |
Why?
|
Vimentin | 3 | 2011 | 27 | 0.140 |
Why?
|
Disulfiram | 1 | 2017 | 4 | 0.140 |
Why?
|
Gene Expression | 3 | 2019 | 415 | 0.140 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2017 | 4 | 0.140 |
Why?
|
Thyroid Carcinoma, Anaplastic | 1 | 2017 | 2 | 0.140 |
Why?
|
Neoplastic Stem Cells | 2 | 2017 | 140 | 0.140 |
Why?
|
Cyclophosphamide | 1 | 2017 | 41 | 0.140 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2017 | 14 | 0.140 |
Why?
|
Carcinoma, Papillary | 1 | 2017 | 18 | 0.140 |
Why?
|
Prodrugs | 1 | 2017 | 30 | 0.140 |
Why?
|
Thymus Gland | 1 | 2017 | 53 | 0.130 |
Why?
|
Frankincense | 1 | 2016 | 1 | 0.130 |
Why?
|
Gingiva | 1 | 2016 | 8 | 0.130 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2017 | 72 | 0.130 |
Why?
|
Legionnaires' Disease | 1 | 2016 | 1 | 0.130 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 39 | 0.130 |
Why?
|
Sirolimus | 1 | 2017 | 76 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2016 | 16 | 0.130 |
Why?
|
RNA, Messenger | 2 | 2019 | 657 | 0.130 |
Why?
|
Cauda Equina | 1 | 2016 | 5 | 0.130 |
Why?
|
Ganglia | 1 | 2016 | 9 | 0.130 |
Why?
|
Choristoma | 1 | 2016 | 6 | 0.130 |
Why?
|
Macrophages | 1 | 2019 | 292 | 0.130 |
Why?
|
Angiogenesis Inhibitors | 1 | 2017 | 109 | 0.130 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2016 | 18 | 0.130 |
Why?
|
Docosahexaenoic Acids | 1 | 2017 | 91 | 0.130 |
Why?
|
Low Back Pain | 1 | 2016 | 28 | 0.130 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 1561 | 0.120 |
Why?
|
Eye Proteins | 1 | 2017 | 205 | 0.120 |
Why?
|
Interferon-gamma | 1 | 2016 | 107 | 0.120 |
Why?
|
Hematoma, Subdural, Chronic | 1 | 2015 | 7 | 0.120 |
Why?
|
Down-Regulation | 2 | 2017 | 199 | 0.120 |
Why?
|
Inflammation | 2 | 2017 | 629 | 0.120 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 474 | 0.120 |
Why?
|
Resins, Plant | 2 | 2012 | 3 | 0.120 |
Why?
|
Infant | 4 | 2014 | 987 | 0.120 |
Why?
|
Treatment Outcome | 3 | 2014 | 2367 | 0.120 |
Why?
|
Sarcoma | 1 | 2015 | 29 | 0.120 |
Why?
|
Amyloidosis | 1 | 2015 | 9 | 0.120 |
Why?
|
Adolescent | 6 | 2019 | 3104 | 0.120 |
Why?
|
Carcinogenesis | 1 | 2015 | 81 | 0.120 |
Why?
|
Monocytes | 1 | 2016 | 135 | 0.120 |
Why?
|
Complement C3 | 1 | 2015 | 21 | 0.120 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2014 | 3 | 0.120 |
Why?
|
Guided Tissue Regeneration | 1 | 2014 | 4 | 0.120 |
Why?
|
Cranial Irradiation | 1 | 2014 | 12 | 0.120 |
Why?
|
Spheroids, Cellular | 3 | 2021 | 53 | 0.120 |
Why?
|
Re-Epithelialization | 1 | 2014 | 5 | 0.120 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 60 | 0.120 |
Why?
|
Muscles | 3 | 2022 | 72 | 0.120 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2014 | 300 | 0.120 |
Why?
|
Mucous Membrane | 1 | 2014 | 28 | 0.120 |
Why?
|
Aging | 2 | 2014 | 968 | 0.120 |
Why?
|
Endothelin-1 | 1 | 2014 | 10 | 0.110 |
Why?
|
Extracellular Matrix Proteins | 1 | 2014 | 28 | 0.110 |
Why?
|
Phosphorylation | 4 | 2019 | 574 | 0.110 |
Why?
|
Hyaluronan Receptors | 1 | 2014 | 31 | 0.110 |
Why?
|
Endothelial Cells | 4 | 2010 | 350 | 0.110 |
Why?
|
Recombination, Genetic | 1 | 2014 | 62 | 0.110 |
Why?
|
Spinal Diseases | 1 | 2015 | 43 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 125 | 0.110 |
Why?
|
Mesenchymoma | 1 | 2014 | 1 | 0.110 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2014 | 2 | 0.110 |
Why?
|
Ganglioneuroma | 1 | 2014 | 4 | 0.110 |
Why?
|
Tongue Neoplasms | 1 | 2014 | 6 | 0.110 |
Why?
|
Liver | 2 | 2019 | 433 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 113 | 0.110 |
Why?
|
Autocrine Communication | 1 | 2013 | 7 | 0.110 |
Why?
|
Neoplasm Invasiveness | 3 | 2021 | 188 | 0.110 |
Why?
|
Paracrine Communication | 1 | 2013 | 17 | 0.110 |
Why?
|
Growth Hormone | 1 | 2014 | 103 | 0.110 |
Why?
|
Survival Analysis | 3 | 2021 | 287 | 0.110 |
Why?
|
Polymers | 2 | 2020 | 117 | 0.110 |
Why?
|
Brain Ischemia | 1 | 2014 | 85 | 0.100 |
Why?
|
Lymphoproliferative Disorders | 1 | 2013 | 5 | 0.100 |
Why?
|
Biomechanical Phenomena | 3 | 2021 | 179 | 0.100 |
Why?
|
Plant Gums | 1 | 2012 | 3 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2013 | 28 | 0.100 |
Why?
|
Retrospective Studies | 4 | 2021 | 2541 | 0.100 |
Why?
|
Necrosis | 3 | 2021 | 83 | 0.100 |
Why?
|
Brain Diseases | 1 | 2013 | 35 | 0.100 |
Why?
|
Mice, Transgenic | 4 | 2017 | 507 | 0.100 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2013 | 27 | 0.100 |
Why?
|
Young Adult | 5 | 2019 | 2714 | 0.100 |
Why?
|
Cytogenetics | 1 | 2012 | 5 | 0.100 |
Why?
|
Oxidative Stress | 1 | 2017 | 667 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2012 | 37 | 0.100 |
Why?
|
Needles | 2 | 2022 | 26 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2010 | 178 | 0.100 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2011 | 1 | 0.090 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 82 | 0.090 |
Why?
|
Bone Marrow | 1 | 2012 | 76 | 0.090 |
Why?
|
Dideoxynucleosides | 1 | 2011 | 12 | 0.090 |
Why?
|
Heart Rate | 2 | 2010 | 379 | 0.090 |
Why?
|
Nitrogen Oxides | 2 | 2021 | 41 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 129 | 0.090 |
Why?
|
Radiopharmaceuticals | 1 | 2011 | 71 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 107 | 0.090 |
Why?
|
Vena Cava, Superior | 1 | 2010 | 27 | 0.090 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 99 | 0.090 |
Why?
|
Meningeal Neoplasms | 1 | 2011 | 73 | 0.090 |
Why?
|
Heart Conduction System | 2 | 2010 | 270 | 0.090 |
Why?
|
Thoracic Vertebrae | 2 | 2015 | 66 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2017 | 247 | 0.090 |
Why?
|
S100 Proteins | 2 | 2013 | 5 | 0.090 |
Why?
|
Students, Medical | 1 | 2012 | 96 | 0.090 |
Why?
|
Ganglia, Autonomic | 1 | 2010 | 55 | 0.090 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 55 | 0.080 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 198 | 0.080 |
Why?
|
Action Potentials | 1 | 2010 | 196 | 0.080 |
Why?
|
Bronchoscopy | 1 | 2010 | 34 | 0.080 |
Why?
|
Cystitis | 1 | 2009 | 11 | 0.080 |
Why?
|
Cryptorchidism | 1 | 2009 | 10 | 0.080 |
Why?
|
Gold | 2 | 2021 | 130 | 0.080 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2009 | 38 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 327 | 0.080 |
Why?
|
Materials Testing | 3 | 2020 | 89 | 0.080 |
Why?
|
Leukocytes | 1 | 2009 | 70 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2009 | 632 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2021 | 450 | 0.080 |
Why?
|
Reproducibility of Results | 1 | 2012 | 769 | 0.080 |
Why?
|
Cell Cycle | 3 | 2019 | 161 | 0.080 |
Why?
|
DNA Copy Number Variations | 2 | 2021 | 36 | 0.080 |
Why?
|
Models, Biological | 3 | 2019 | 466 | 0.080 |
Why?
|
STAT3 Transcription Factor | 2 | 2019 | 97 | 0.080 |
Why?
|
Stromal Cells | 2 | 2006 | 60 | 0.080 |
Why?
|
Heme Oxygenase-1 | 2 | 2020 | 36 | 0.080 |
Why?
|
Plant Extracts | 1 | 2009 | 62 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2009 | 55 | 0.080 |
Why?
|
Astrocytes | 2 | 2014 | 77 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 62 | 0.080 |
Why?
|
3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 1 | 2008 | 1 | 0.080 |
Why?
|
Blotting, Western | 2 | 2010 | 510 | 0.080 |
Why?
|
Urogenital System | 1 | 2008 | 3 | 0.080 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2008 | 3 | 0.080 |
Why?
|
Internship and Residency | 1 | 2012 | 239 | 0.080 |
Why?
|
Databases, Factual | 2 | 2021 | 253 | 0.080 |
Why?
|
Multienzyme Complexes | 1 | 2008 | 29 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 3 | 2016 | 156 | 0.070 |
Why?
|
Health Education | 1 | 2009 | 71 | 0.070 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2008 | 3 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2009 | 97 | 0.070 |
Why?
|
Prostaglandin D2 | 1 | 2008 | 6 | 0.070 |
Why?
|
X-Ray Microtomography | 2 | 2020 | 32 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2008 | 117 | 0.070 |
Why?
|
Tumor Burden | 2 | 2019 | 110 | 0.070 |
Why?
|
Neoplasms | 1 | 2017 | 803 | 0.070 |
Why?
|
Heterografts | 2 | 2018 | 66 | 0.070 |
Why?
|
Biomedical Research | 1 | 2009 | 96 | 0.070 |
Why?
|
Disease-Free Survival | 2 | 2019 | 237 | 0.070 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2008 | 96 | 0.070 |
Why?
|
Neoplasm Transplantation | 2 | 2019 | 89 | 0.070 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2007 | 12 | 0.070 |
Why?
|
Autonomic Nervous System | 1 | 2008 | 112 | 0.070 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2007 | 25 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2013 | 103 | 0.070 |
Why?
|
Heart Atria | 1 | 2008 | 175 | 0.070 |
Why?
|
Drug Synergism | 2 | 2017 | 104 | 0.070 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 134 | 0.070 |
Why?
|
Amyloid beta-Peptides | 1 | 2007 | 49 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2017 | 58 | 0.070 |
Why?
|
Coculture Techniques | 2 | 2019 | 55 | 0.070 |
Why?
|
Prostatic Diseases | 1 | 2006 | 3 | 0.060 |
Why?
|
Immunoenzyme Techniques | 1 | 2006 | 67 | 0.060 |
Why?
|
In Vitro Techniques | 2 | 2017 | 241 | 0.060 |
Why?
|
Up-Regulation | 2 | 2021 | 246 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2017 | 287 | 0.060 |
Why?
|
RNA-Binding Protein EWS | 1 | 2005 | 7 | 0.060 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2005 | 7 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 94 | 0.060 |
Why?
|
Drug Design | 1 | 2006 | 63 | 0.060 |
Why?
|
Administration, Oral | 2 | 2016 | 188 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 77 | 0.060 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2004 | 21 | 0.060 |
Why?
|
Dogs | 3 | 2010 | 509 | 0.060 |
Why?
|
Estradiol | 2 | 2019 | 175 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2004 | 67 | 0.060 |
Why?
|
Pilot Projects | 2 | 2021 | 430 | 0.060 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 249 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 268 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2015 | 60 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2017 | 1011 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2008 | 402 | 0.050 |
Why?
|
Permeability | 2 | 2017 | 61 | 0.050 |
Why?
|
Synucleins | 1 | 2003 | 1 | 0.050 |
Why?
|
beta-Synuclein | 1 | 2003 | 1 | 0.050 |
Why?
|
gamma-Synuclein | 1 | 2003 | 2 | 0.050 |
Why?
|
alpha-Synuclein | 1 | 2003 | 4 | 0.050 |
Why?
|
Oligodendroglia | 1 | 2003 | 15 | 0.050 |
Why?
|
Cystectomy | 2 | 2014 | 103 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2003 | 94 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 343 | 0.050 |
Why?
|
Dynamin II | 1 | 2022 | 13 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2022 | 15 | 0.050 |
Why?
|
Adenosine Monophosphate | 1 | 2022 | 21 | 0.050 |
Why?
|
Dextrans | 1 | 2022 | 23 | 0.050 |
Why?
|
Syndecan-1 | 1 | 2022 | 13 | 0.050 |
Why?
|
Epidural Space | 1 | 2022 | 11 | 0.050 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2022 | 41 | 0.050 |
Why?
|
Supervised Machine Learning | 1 | 2022 | 8 | 0.050 |
Why?
|
Esophagitis, Peptic | 1 | 2002 | 5 | 0.050 |
Why?
|
Antacids | 1 | 2002 | 6 | 0.050 |
Why?
|
Calcium Carbonate | 1 | 2002 | 6 | 0.050 |
Why?
|
Computers | 1 | 2022 | 30 | 0.050 |
Why?
|
Heartburn | 1 | 2002 | 26 | 0.050 |
Why?
|
Craniotomy | 1 | 2002 | 61 | 0.050 |
Why?
|
Fourier Analysis | 1 | 2022 | 31 | 0.050 |
Why?
|
Cyclin D1 | 1 | 2022 | 38 | 0.050 |
Why?
|
Cell Line | 3 | 2009 | 695 | 0.050 |
Why?
|
Postprandial Period | 1 | 2002 | 44 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 66 | 0.050 |
Why?
|
Nerve Regeneration | 1 | 2021 | 12 | 0.050 |
Why?
|
Gelatin | 1 | 2021 | 11 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2021 | 43 | 0.050 |
Why?
|
Chromosomes | 1 | 2022 | 59 | 0.050 |
Why?
|
Axons | 1 | 2021 | 24 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2018 | 403 | 0.050 |
Why?
|
Thromboplastin | 1 | 2021 | 28 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2021 | 32 | 0.050 |
Why?
|
Anisotropy | 1 | 2021 | 28 | 0.040 |
Why?
|
Microarray Analysis | 1 | 2021 | 64 | 0.040 |
Why?
|
Lipids | 1 | 2022 | 207 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 95 | 0.040 |
Why?
|
ROC Curve | 1 | 2021 | 143 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 225 | 0.040 |
Why?
|
Carbonic Anhydrase IX | 1 | 2020 | 3 | 0.040 |
Why?
|
Inhibins | 1 | 2020 | 8 | 0.040 |
Why?
|
Receptors, Somatostatin | 1 | 2020 | 8 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2022 | 251 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 34 | 0.040 |
Why?
|
Septum Pellucidum | 1 | 2019 | 3 | 0.040 |
Why?
|
Rheology | 1 | 2020 | 22 | 0.040 |
Why?
|
Cross-Linking Reagents | 1 | 2020 | 42 | 0.040 |
Why?
|
RNA, Long Noncoding | 1 | 2020 | 31 | 0.040 |
Why?
|
Dihydrotestosterone | 2 | 2010 | 9 | 0.040 |
Why?
|
Chickens | 1 | 2019 | 61 | 0.040 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2019 | 15 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2019 | 33 | 0.040 |
Why?
|
Fluorouracil | 1 | 2019 | 58 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2020 | 136 | 0.040 |
Why?
|
Receptors, Notch | 1 | 2019 | 45 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2020 | 60 | 0.040 |
Why?
|
Pressure | 1 | 2020 | 90 | 0.040 |
Why?
|
Fish Oils | 1 | 2019 | 12 | 0.040 |
Why?
|
Rabbits | 1 | 2020 | 276 | 0.040 |
Why?
|
MCF-7 Cells | 1 | 2019 | 34 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 35 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 180 | 0.040 |
Why?
|
Biotinylation | 1 | 2019 | 19 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2020 | 148 | 0.040 |
Why?
|
Liposomes | 1 | 2020 | 145 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2010 | 194 | 0.040 |
Why?
|
Datasets as Topic | 1 | 2019 | 22 | 0.040 |
Why?
|
Oligopeptides | 1 | 2020 | 96 | 0.040 |
Why?
|
Chemokine CXCL5 | 1 | 2019 | 7 | 0.040 |
Why?
|
Chemokine CXCL1 | 1 | 2019 | 7 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2021 | 138 | 0.040 |
Why?
|
Immunotherapy | 1 | 2021 | 159 | 0.040 |
Why?
|
Solute Carrier Organic Anion Transporter Family Member 1B3 | 1 | 2019 | 17 | 0.040 |
Why?
|
Microvessels | 1 | 2019 | 87 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2020 | 122 | 0.040 |
Why?
|
Algorithms | 1 | 2022 | 430 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 109 | 0.040 |
Why?
|
Drug Interactions | 1 | 2019 | 79 | 0.040 |
Why?
|
Cerebellum | 1 | 2019 | 40 | 0.040 |
Why?
|
Surface Properties | 1 | 2019 | 134 | 0.040 |
Why?
|
CRISPR-Cas Systems | 1 | 2019 | 48 | 0.040 |
Why?
|
Cisplatin | 1 | 2019 | 179 | 0.040 |
Why?
|
White Matter | 1 | 2019 | 89 | 0.040 |
Why?
|
Transfection | 2 | 2010 | 317 | 0.040 |
Why?
|
Prostatectomy | 1 | 2019 | 83 | 0.040 |
Why?
|
HeLa Cells | 1 | 2019 | 208 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2019 | 186 | 0.040 |
Why?
|
Adrenalectomy | 1 | 2018 | 13 | 0.040 |
Why?
|
Lung | 1 | 2021 | 378 | 0.040 |
Why?
|
Antioxidants | 1 | 2020 | 223 | 0.040 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2018 | 18 | 0.040 |
Why?
|
Cytokine Receptor gp130 | 1 | 2017 | 5 | 0.040 |
Why?
|
Hexokinase | 1 | 2018 | 16 | 0.040 |
Why?
|
Blood Platelets | 1 | 2020 | 205 | 0.040 |
Why?
|
Sheep | 1 | 2018 | 100 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2018 | 35 | 0.040 |
Why?
|
Inflammasomes | 1 | 2017 | 20 | 0.040 |
Why?
|
Adrenal Glands | 1 | 2017 | 21 | 0.040 |
Why?
|
NADPH Oxidases | 1 | 2018 | 69 | 0.040 |
Why?
|
Central Nervous System | 1 | 2017 | 37 | 0.040 |
Why?
|
Peptides | 1 | 2020 | 287 | 0.040 |
Why?
|
Glycolysis | 1 | 2018 | 85 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 60 | 0.030 |
Why?
|
Carbon-Sulfur Lyases | 1 | 2017 | 16 | 0.030 |
Why?
|
Dinoprost | 2 | 2008 | 9 | 0.030 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 176 | 0.030 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2017 | 7 | 0.030 |
Why?
|
Neuroblastoma | 1 | 2017 | 56 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2017 | 7 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2017 | 14 | 0.030 |
Why?
|
Annexin A5 | 1 | 2017 | 24 | 0.030 |
Why?
|
Escherichia coli | 1 | 2020 | 337 | 0.030 |
Why?
|
Cell Separation | 1 | 2017 | 55 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2019 | 240 | 0.030 |
Why?
|
Cell Lineage | 1 | 2017 | 51 | 0.030 |
Why?
|
Genome, Human | 1 | 2017 | 69 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2019 | 217 | 0.030 |
Why?
|
Gene Order | 1 | 2016 | 10 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 546 | 0.030 |
Why?
|
Triterpenes | 1 | 2016 | 9 | 0.030 |
Why?
|
Pyridazines | 1 | 2016 | 8 | 0.030 |
Why?
|
Legionella pneumophila | 1 | 2016 | 5 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2016 | 25 | 0.030 |
Why?
|
Transgenes | 1 | 2016 | 63 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2017 | 165 | 0.030 |
Why?
|
Imidazoles | 1 | 2016 | 63 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2017 | 233 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 284 | 0.030 |
Why?
|
Genomics | 1 | 2017 | 122 | 0.030 |
Why?
|
Laminectomy | 1 | 2016 | 30 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2016 | 114 | 0.030 |
Why?
|
Time Factors | 2 | 2011 | 1590 | 0.030 |
Why?
|
Decorin | 1 | 2015 | 3 | 0.030 |
Why?
|
Sulfatases | 1 | 2015 | 6 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 135 | 0.030 |
Why?
|
Receptors, Complement | 1 | 2015 | 6 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2015 | 170 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2016 | 123 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2014 | 18 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2017 | 836 | 0.030 |
Why?
|
Rats, Mutant Strains | 1 | 2014 | 16 | 0.030 |
Why?
|
Brain Edema | 1 | 2014 | 21 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 34 | 0.030 |
Why?
|
Dwarfism | 1 | 2014 | 27 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 2014 | 26 | 0.030 |
Why?
|
Nanotechnology | 1 | 2014 | 68 | 0.030 |
Why?
|
Melanoma-Specific Antigens | 1 | 2013 | 2 | 0.030 |
Why?
|
gp100 Melanoma Antigen | 1 | 2013 | 2 | 0.030 |
Why?
|
MART-1 Antigen | 1 | 2013 | 3 | 0.030 |
Why?
|
Monophenol Monooxygenase | 1 | 2013 | 5 | 0.030 |
Why?
|
Isonicotinic Acids | 1 | 2013 | 1 | 0.030 |
Why?
|
Picrotoxin | 1 | 2013 | 1 | 0.030 |
Why?
|
GABA Antagonists | 1 | 2013 | 4 | 0.030 |
Why?
|
GABA Agonists | 1 | 2013 | 4 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 21 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2013 | 23 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 114 | 0.030 |
Why?
|
Retina | 1 | 2017 | 430 | 0.030 |
Why?
|
Quinazolines | 1 | 2013 | 32 | 0.030 |
Why?
|
src-Family Kinases | 1 | 2013 | 71 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2012 | 8 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2012 | 14 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2012 | 27 | 0.030 |
Why?
|
Dermatomyositis | 1 | 2013 | 60 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2013 | 49 | 0.030 |
Why?
|
Cell Death | 1 | 2012 | 118 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 185 | 0.020 |
Why?
|
United States | 1 | 2018 | 2139 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2011 | 29 | 0.020 |
Why?
|
CD56 Antigen | 1 | 2011 | 1 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2011 | 22 | 0.020 |
Why?
|
Receptors, Calcitriol | 1 | 2010 | 6 | 0.020 |
Why?
|
Retinoid X Receptors | 1 | 2010 | 24 | 0.020 |
Why?
|
Chick Embryo | 1 | 2010 | 27 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2013 | 984 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 41 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 76 | 0.020 |
Why?
|
Bronchoscopes | 1 | 2010 | 2 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 256 | 0.020 |
Why?
|
Puberty | 1 | 2009 | 13 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2009 | 56 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2009 | 119 | 0.020 |
Why?
|
Equipment Design | 1 | 2010 | 217 | 0.020 |
Why?
|
Computational Biology | 1 | 2010 | 155 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2008 | 7 | 0.020 |
Why?
|
Cytoplasm | 1 | 2008 | 57 | 0.020 |
Why?
|
Receptors, Prostaglandin | 1 | 2008 | 1 | 0.020 |
Why?
|
Neutrophils | 1 | 2009 | 181 | 0.020 |
Why?
|
Chromones | 1 | 2008 | 11 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2008 | 103 | 0.020 |
Why?
|
Organ Specificity | 1 | 2008 | 82 | 0.020 |
Why?
|
Morpholines | 1 | 2008 | 28 | 0.020 |
Why?
|
Urea | 1 | 2008 | 16 | 0.020 |
Why?
|
beta Catenin | 1 | 2008 | 65 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2008 | 73 | 0.020 |
Why?
|
Species Specificity | 1 | 2008 | 191 | 0.020 |
Why?
|
Particle Size | 1 | 2008 | 101 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 135 | 0.020 |
Why?
|
Cytokines | 1 | 2009 | 446 | 0.020 |
Why?
|
Neuroglia | 1 | 2007 | 30 | 0.020 |
Why?
|
Wound Healing | 1 | 2008 | 124 | 0.020 |
Why?
|
Endosomes | 1 | 2007 | 45 | 0.020 |
Why?
|
Immunization | 1 | 2007 | 119 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2007 | 83 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2007 | 108 | 0.020 |
Why?
|
Antibodies | 1 | 2007 | 124 | 0.020 |
Why?
|
Catheter Ablation | 1 | 2008 | 221 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 1 | 2006 | 24 | 0.020 |
Why?
|
Testosterone | 1 | 2006 | 72 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2007 | 281 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 208 | 0.020 |
Why?
|
Age Factors | 1 | 2007 | 733 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2004 | 15 | 0.010 |
Why?
|
Cross Reactions | 1 | 2004 | 72 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2007 | 220 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2004 | 136 | 0.010 |
Why?
|
Breast | 1 | 2004 | 52 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2004 | 114 | 0.010 |
Why?
|
Dosage Forms | 1 | 2002 | 5 | 0.010 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2002 | 27 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2002 | 267 | 0.010 |
Why?
|